C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis

Tuesday, August 31, 2021

ANI Pharmaceuticals Inc today announced that the Companys supplemental New Drug Application sNDA for Purified Cortrophin Gel Cortrophin Gel has been accepted by the US Food and Drug Administration FDA for review FDAs acceptance of our sNDA for Cortro...

Verily Completes Acquisition of SignalPath, Expanding Company's Clinical Research Capabilities and Marking Company's First Major Acquisition

Tuesday, August 31, 2021

Verily an Alphabet company today announced that its previously announced acquisition of SignalPath a privately held company that makes clinical research software based in Raleigh has successfully closed The acquisition will strengthen and expand Veri...

Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia

Tuesday, August 31, 2021

Teva Pharmaceuticals a US affiliate of Teva Pharmaceutical Industries Ltd and MedinCell announced today that the New Drug Application NDA for TVmdcIRM risperidone extendedrelease injectable suspension for subcutaneous use for the treatment of schizop...

Eisai and FUJI YAKUHIN Conclude License Agreement Concerning the Development and Distribution of Dotinurad, a Treatment for Hyperuricemia and Gout, in Five ASEAN Countries

Tuesday, August 31, 2021

Eisai Co Ltd and FUJI YAKUHIN CO LTD announced today that they have concluded a license agreement concerning dotinurad generic name a treatment for hyperuricemia and gout discovered by FUJI YAKUHIN for development and distribution in five ASEAN Assoc...

SpringWorks Therapeutics Enters into Research Collaboration with Leading Cancer Institute to Further Evaluate Nirogacestat as a BCMA Potentiator in Multiple Myeloma

Monday, August 30, 2021

SpringWorks Therapeutics Inc a clinicalstage biopharmaceutical company focused on developing lifechanging medicines for patients with severe rare diseases and cancer today announced that it has entered into a sponsored research collaboration with Dan...

XPhyto Launches First Commercial Biosensor for Oral Disease

Monday, August 30, 2021

XPhyto Therapeutics Corp with its partner and acquisition target adiagnostics GmbH a has successfully registered their first biosensor test in oral inflammation with the German authorities cosmetic products notification The easy athome selfcheck can...

Bio-Thera Solutions and Hikma Pharmaceuticals announce exclusive commercialization and license agreement for BAT2206 in the US, a proposed biosimilar referencing Stelara® (ustekinumab)

Friday, August 27, 2021

BioThera Solutions Ltd and Hikma Pharmaceuticals PLC announced that they have entered into a commercialization and license agreement to commercialize BAT a monoclonal antibody that is a proposed biosimilar referencing Stelara ustekinumab in the Unite...

ImmixBio Announces Clinical Trial and Supply Agreement with BeiGene to Evaluate Combination of IMX-110 and Tislelizumab in Solid Tumors

Friday, August 27, 2021

Immix Biopharma Inc announced a clinical trial and supply agreement with BeiGene Ltd to evaluate the safety tolerability and efficacy of combining IMX a Tissue Specific Therapeutic with TME Normalization Technology with BeiGenes antiPD antibody tisle...

Global Genes Launches RARE Patient Identification and Inclusion Initiative

Thursday, August 26, 2021

Global Genes a leading international rare disease advocacy organization today announced the launch of a Patient Identification and Engagement for RARE CNS Disorders PIECNS multistakeholder initiative The PIECNS initiative will address major gaps in t...

Landos Biopharma Announces Research Collaboration into the NLRX1 Pathway in Multiple Sclerosis with Johns Hopkins University School of Medicine

Thursday, August 26, 2021

Landos Biopharma Inc a lateclinicalstage biopharmaceutical company utilizing its LANCE Advanced AI platform to develop novel oral therapeutics for patients with autoimmune diseases today announced that it has entered into a research collaboration wit...